Guidance For Industry (May 1998):Providing Clinical Evidence of Effectiveness for Human Drug and Biological Products

• Agency’s current thinking on quantity of evidence to support effectiveness

• Effectiveness may be extrapolated from efficacy data for another claim or product, e.g.,

  • Pediatric uses
  • Bioequivalence
  • Modified-release dosage forms
  • Different doses, regimens or dosage forms

Previous slide

Next slide

Back to first slide

View graphic version